Oramed Pharmaceuticals Inc. (ORMP) — Stock Score Summary

Oramed Pharmaceuticals Inc. (ORMP) has a MoatMap StockRank of 95/100 based on Quality (64/100), Value (63/100), and Momentum (59/100) factor scores. The current signal is STRONG BUY. Oramed Pharmaceuticals is a speculative biotech firm with binary clinical trial risks, failing our Terry Smith quality filter and lacking clear macro thematic tailwinds.

Oramed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company pioneering oral drug delivery systems, notably an oral insulin capsule for diabetes. Its proprietary POD™ technology aims to transform injectable treatments into convenient oral alternatives, offering significant potential market disruption. Oramed is a biotech player developing innovative solutions for chronic diseases.

Key Financial Metrics

Price$3.65
Market Cap$162M
P/E (TTM)1.47
P/E (Forward)-47.63
Price/Book0.75
Return on Equity58.2%
Return on Invested Capital35.6%
Debt/Equity0.32
Gross Margin0.0%
Operating Margin0.0%
Dividend Yield6.6%
Free Cash Flow$251K

Oramed Pharmaceuticals Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Oramed Pharmaceuticals Inc.’s (ORMP) StockRank?
MoatMap’s StockRank for Oramed Pharmaceuticals Inc. (ORMP) is 95/100, with a Strong Buy signal. It is a composite of Quality (64), Value (63), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Oramed Pharmaceuticals Inc. have an economic moat?
Oramed Pharmaceuticals Inc. (ORMP) has a Quality factor score of 64/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Oramed Pharmaceuticals Inc. a buy, hold, or sell?
MoatMap’s current signal for Oramed Pharmaceuticals Inc. (ORMP) is Strong Buy, based on a StockRank of 95/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Oramed Pharmaceuticals Inc. in?
Oramed Pharmaceuticals Inc. (ORMP) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksORMP deep dive reportAI ChampionsHow we score stocksSense-check another stock